Clinical Trials on Muscle-Invasive Bladder Carcinoma in South Africa
Total 138 results
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Telormedix SACompletedCarcinoma in Situ | Non Muscle Invasive Bladder CancerUnited States
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Ferring PharmaceuticalsFKD Therapies Oy; Society of Urologic Oncology Clinical Trials ConsortiumCompletedSuperficial Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerRecurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7United States, Canada
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Asieris Pharmaceutical Technologies Co., Ltd.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
National and Kapodistrian University of AthensCompleted
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
National Cancer Institute (NCI)RecruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.RecruitingUrinary Bladder Cancer, Muscle-invasiveUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Mexico, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Thailand, T... and more
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
National Cancer Institute (NCI)RecruitingStage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditionsUnited States, Puerto Rico
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Medical University of South CarolinaTerminatedNewly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-IIUnited States
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States